After a rapid rise, Eli Lilly needs only an 11% gain to hit $1 trillion in market value. Revenue is expected to rise 26% next ...

The past week, ending November 7, saw U.S. artificial intelligence-related stocks retreat amid mounting valuation concerns.

Full compatibility with US carriers, apps, and services is guaranteed with the 2024 US version with no regional or software ...

With the Christmas shopping season just beginning, here are some tips to avoid falling for false sales of the year's hot toys ...

Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.

Bulls believe it's a 'huge and explosive' opportunity, while sceptics see a 'momentum-fuelled bubble' destined to pop.

The upper chamber of the Legislature could see as many as seven new members by 2027. But that wouldn't be the biggest ...

A big demo project, storage research and task force recommendations seek to advance U.S. cleancoal technology, but financing ...

Merck & Co. has agreed to acquire Cidara Therapeutics for approximately $9.2 billion, the companies said, in a deal designed to bolster the buyer’s antiviral portfolio with a Phase III drug designed ...

Project Unveils 'Kamirex Exchange' to Bridge Asian Liquidity Gaps and a Flagship Action-RPG Game Aiming for PlayStation/Xbox, Announcing a Token Generation Event (TGE) Driven by Overwhelming Utility ...

Democratic strategist Simon Bazelon says the party has changed a lot since 2012, resulting in election losses.

Many New Zealand retailers are adopting artificial intelligence to remain competitive against global shopping websites, but ...